First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Clinical trial NCT00339586 · UNKNOWN
Trial details
- NCT number
- NCT00339586
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.